Succinylcholine is one of those anesthesia medications that aspiring CRNAs, ICU nurses, SRNAs, and CRNA applicants should understand well. Even though it has been used in anesthesia practice for decades, it still shows up in modern airway management because of its rapid onset and short duration.
In this episode, Dr. Michelle Ballister, CRNA and CSPA faculty coach, breaks down how succinylcholine works at the neuromuscular junction, why it is still used for rapid sequence intubation, and what makes its side effect profile worth respecting.
This topic matters because succinylcholine connects pharmacology, anatomy, physiology, airway management, and patient safety. For anyone preparing for CRNA school interviews or building stronger clinical knowledge as an ICU nurse, understanding this medication can help you think more like an anesthesia provider.
Transcript note: The provided transcript appears to cut off during the discussion of increased intracranial pressure. This blog only includes details supported by the available transcript.
Key Takeaways
- Succinylcholine is a depolarizing neuromuscular blocker with a rapid onset, often allowing intubating conditions within 30 to 60 seconds.
- Its short duration depends on normal plasma cholinesterase activity, which helps break the drug down in the bloodstream.
- There is no reversal agent for succinylcholine, so recovery depends on time and the patient’s ability to metabolize the medication.
- Succinylcholine can increase serum potassium, which makes patient selection especially important.
Certain patients, including those with burns, stroke, spinal cord injury, prolonged immobility, or hyperkalemia, may be at higher risk for complications. - Understanding the neuromuscular junction helps explain both the benefits and risks of succinylcholine.
Get the Free CRNA School Data Sheet!
Compare every CRNA program’s requirements, deadlines, and interview details, all in one organized spreadsheet. The CRNA School Data Sheet helps you filter programs by ICU experience requirements, GRE, CCRN, last 60 credit GPA, and more so you can build a smarter school list without the confusion.
It’s updated regularly by the CSPA team, making it the easiest way to research and track CRNA school requirements. Bookmark it, plan your next steps, and finally feel confident that you’re staying on top of every requirement.
Access it free here: https://community.
Join Us for Gassed Up: Fired Up for CRNA School The CSPA 2026 Conference
June 12th – 14th at the University of Louisville, KY
Ticket and Agenda Information: https://events.
Want Guaranteed CRNA School Admission?
Learn how CSPA’s Personalized Money-Back Guarantee sets you up for success:
https://community.
Get access to application and interview preparation resources plus ICU Educational Workshops that have helped thousands of nurses accelerate their CRNA success. Become a member of CRNA School Prep Academy:
https://community.
—
Watch the episode here
Listen to the podcast here
Welcome to the CRNA School Prep Academy Podcast
Welcome to the CRNA School Prep Academy Podcast, where we have helped guide more than 10,000 ICU nurses on their path toward CRNA school. Our mission is to combine education, guidance, and professional growth so you can move confidently toward your goal of becoming a CRNA.
Whether you are still in nursing school or you are a seasoned ICU nurse, this podcast is here for you.
In this clinical teaching episode, Dr. Michelle Ballister, CRNA and CSPA faculty coach, walks through the pharmacology and clinical considerations of succinylcholine. This is a helpful review for ICU nurses preparing for CRNA school, SRNAs building their anesthesia foundation, and applicants who want to strengthen the way they connect pharmacology to patient care.
Why Succinylcholine Still Matters in Anesthesia Practice
Succinylcholine has been part of anesthesia practice since the early 1950s. That alone raises a fair question: why is such an old drug still used today?
Dr. Ballister explains that succinylcholine entered clinical anesthesia practice around the same era as mechanical ventilation. Before modern ventilators, anesthesia providers had much different airway and ventilation tools. The introduction of muscle relaxants and mechanical ventilation changed the way anesthesia was delivered, but it also came with a learning curve.
Early use of muscle relaxants created new patient management challenges. Providers had to learn how to manage paralysis, ventilation, duration of action, and recovery. Over time, anesthesia practice became much safer and more refined, but succinylcholine remained part of the toolkit because of one major advantage: speed.
Succinylcholine can create intubating conditions quickly, often within 30 to 60 seconds. That rapid onset is one of the biggest reasons it is still used in modern anesthesia, especially when the airway needs to be secured quickly.
A Quick Review of the Neuromuscular Junction
To understand succinylcholine, you need to understand the neuromuscular junction.
The neuromuscular junction is where a nerve signal communicates with skeletal muscle. When an electrical impulse reaches the nerve ending, acetylcholine is released. Acetylcholine then binds to nicotinic receptors on the muscle cell.
Those nicotinic receptors act like ion channels. Once acetylcholine binds, the channel opens. Sodium and calcium move into the cell, while potassium moves out. This shift in electrolytes helps the muscle cell depolarize.
Then acetylcholinesterase breaks down acetylcholine, allowing the muscle cell to repolarize and prepare for the next signal. This process happens incredibly fast and usually without us ever thinking about it.
For CRNA school applicants, this is a great example of why anatomy, physiology, and pharmacology are so connected in anesthesia. The drug’s clinical effects make much more sense once you understand what is happening at the receptor level.
How Succinylcholine Works
Succinylcholine is structurally similar to acetylcholine. Dr. Ballister describes it as two conjoined acetylcholine molecules. Because it resembles acetylcholine, it can bind to the nicotinic receptor and activate it.
The result is depolarization.
Unlike acetylcholine, succinylcholine is not broken down right at the neuromuscular junction by acetylcholinesterase. Instead, it has to diffuse away from the receptor and return to the bloodstream. Once it is back in circulation, it is metabolized by plasma cholinesterase, also called pseudocholinesterase.
This explains two important things about the drug:
- It works very quickly.
- Its duration depends on the patient’s ability to metabolize it.
In a patient with normal plasma cholinesterase activity, succinylcholine typically wears off within several minutes, with recovery often expected by around 15 minutes after an intubating dose.
Why Succinylcholine Has No Sedation Effect
One point Dr. Ballister emphasizes is that succinylcholine does not provide sedation.
Succinylcholine is a quaternary ammonium compound. Because of its charge, it does not cross the blood-brain barrier. That means it does not create central nervous system sedation.
This is an important clinical concept for aspiring CRNAs. Muscle relaxation and sedation are not the same thing. A paralyzed patient is not automatically unconscious, sedated, or amnestic. That distinction matters deeply in anesthesia practice and patient safety.
Dr. Ballister also notes that succinylcholine does not cross the placenta in a way that creates the same concerns for the fetus as drugs that freely cross into fetal circulation.
Succinylcholine Onset and Duration
One reason succinylcholine remains clinically useful is its rapid onset. Dr. Ballister explains that paralysis adequate for intubation can occur within about 30 to 60 seconds.
That matters most during rapid sequence intubation. In patients at high risk for aspiration or in situations where the airway needs to be secured quickly, a fast-onset paralytic can be useful.
The duration is also relatively short for many patients. Recovery may occur within 8 to 10 minutes, sometimes closer to 13 to 15 minutes depending on the source and the patient. However, that expected recovery depends on normal plasma cholinesterase function.
There is no reversal agent for succinylcholine. Recovery depends on time and metabolism.
Plasma Cholinesterase and Delayed Recovery
Plasma cholinesterase is the enzyme responsible for breaking down succinylcholine in the bloodstream. If a patient has abnormal or low plasma cholinesterase activity, they may stay paralyzed longer than expected.
Dr. Ballister discusses atypical pseudocholinesterase, which can be genetic. Patients may be heterozygous, meaning they have one normal gene and one abnormal gene, or homozygous, meaning they have two abnormal genes.
A heterozygous patient may have some enzyme activity, but not enough to metabolize succinylcholine in the expected timeframe.
A homozygous patient may have very little or no functional enzyme activity. In that case, paralysis can last much longer than expected and may require prolonged ventilatory support.
This is one reason family history matters. Patients may not know they have atypical pseudocholinesterase until they or a family member has an unexpected prolonged response to succinylcholine.
Conditions That Can Affect Plasma Cholinesterase Activity
Dr. Ballister also explains that some clinical conditions can decrease plasma cholinesterase activity or slow drug metabolism.
Examples discussed in the episode include:
- Hypothermia
- Liver failure
- Renal failure, especially with uremia
- Severe liver disease
- Acute infection
- Pregnancy
- Plasmapheresis
- Older age, especially in males
Since plasma cholinesterase is produced by the liver, liver dysfunction can be especially relevant. Pregnancy can also decrease plasma cholinesterase levels, partly due to increased blood volume and dilutional effects.
Some conditions may increase plasma cholinesterase activity, including obesity with diabetes, hemochromatosis, and thyrotoxicosis.
For CRNA school preparation, this is a strong reminder that pharmacology is never isolated. Patient physiology, disease states, temperature, and history all influence how a drug behaves.
Why Patient Selection Matters With Succinylcholine
Succinylcholine has a fast onset, but it also has a side effect profile that requires respect.
Dr. Ballister describes it as a drug that can feel “dirty” when you first learn about all the potential adverse effects. Still, there are clinical moments where its rapid onset makes it valuable.
The decision to use succinylcholine is not simply about memorizing the dose or knowing that it works quickly. It requires the provider to look at the patient’s condition, airway risk, potassium status, history, and potential contraindications.
This is the kind of thinking CRNA programs want applicants to develop. Strong candidates do not just memorize medications. They understand why a medication may be appropriate for one patient and risky for another.
Hyperkalemia Risk With Succinylcholine
One of the most important adverse effects Dr. Ballister discusses is potassium release.
A single dose of succinylcholine can raise serum potassium by approximately 0.5 to 1 mEq/L. This happens because succinylcholine opens the nicotinic receptor ion channel, allowing potassium to move out of the cell.
For many patients, this may be tolerated. But in patients who are already hyperkalemic or at risk for excess potassium release, that increase can be dangerous.
Dr. Ballister specifically mentions concern for patients such as:
- Burn patients
- Stroke patients
- Spinal cord injury patients
- Patients with prolonged immobility
- Patients who are already hyperkalemic
In these patients, the body may create more nicotinic receptors outside the normal neuromuscular junction. When succinylcholine reaches those receptors, potassium can still leak out, even if the drug is not creating the intended muscle effect in the usual way.
This is why succinylcholine is not a “one-size-fits-all” medication. The patient’s condition changes the risk.
Cardiac Effects and Bradycardia
Succinylcholine can also affect the autonomic nervous system because nicotinic receptors are found there as well.
Dr. Ballister notes that dysrhythmias can occur, especially bradycardia. Bradycardia is often discussed in pediatric patients receiving succinylcholine, and it may also occur in adults after a second dose.
This is another reason anesthesia providers pay close attention to the whole clinical picture. A medication used to create skeletal muscle paralysis can still have effects outside the skeletal muscle system.
Fasciculations and Postoperative Myalgias
Many clinicians have seen the classic fasciculations that can occur after succinylcholine administration.
These fasciculations happen because muscle cells depolarize in a disorganized way. The patient may appear to have brief muscle twitching or movement after the medication is given.
Dr. Ballister explains that patients with stronger muscle tone, such as athletic males or athletic females, may show more visible fasciculations. Very young and very old patients may show less.
These fasciculations can lead to postoperative myalgias, or muscle soreness, usually 24 to 48 hours later. Patients may describe it as feeling like they had a hard workout. It can often be treated with medications such as NSAIDs or acetaminophen when appropriate, but it can still be uncomfortable.
Intragastric Pressure and Lower Esophageal Sphincter Tone
Succinylcholine can increase intragastric pressure due to fasciculations in the trunk and abdominal muscles. At first glance, that sounds concerning because increased stomach pressure could raise aspiration risk.
However, Dr. Ballister explains that succinylcholine also increases lower esophageal sphincter tone. These effects may counterbalance each other.
Because of that balance, this particular effect is not usually the main deciding factor when considering succinylcholine.
Intraocular Pressure and Intracranial Pressure
Succinylcholine can increase intraocular pressure, which is thought to happen due to contraction of the muscles around the eye. Dr. Ballister notes that this is a theoretical concern in patients with eye injuries, especially penetrating eye injuries.
The transcript also begins discussing increased intracranial pressure, but the provided transcript cuts off before the full explanation is complete. Because of that, this blog does not expand beyond what was included in the transcript.
Practical Takeaway for Aspiring CRNAs
Succinylcholine is a great medication to study because it forces you to connect multiple areas of anesthesia knowledge.
You need to understand receptor physiology. You need to understand metabolism. You need to recognize the importance of patient selection. You need to think about airway urgency, aspiration risk, potassium shifts, and the fact that paralysis is not sedation.
For CRNA school applicants, this is the kind of topic that can show up in interviews because it reveals how you think. It is not enough to say succinylcholine is fast. You should be able to explain why it is fast, when it may be useful, and when it may be risky.
Related Topics to Explore
What Is A CRNA? How Do You Become A CRNA? Plus CRNA Salary Information and the Top 10 Best CRNA Programs! – Learn what CRNAs do, how to become one, and what salary and program details matter most before applying.
CRNA School Cost: A Comprehensive Guide to Paying for CRNA School — Explore realistic costs and financing options for future CRNAs.
Why Your CRNA School Interview Matters Most – Discover why your interview can make or break your CRNA application and how to stand out when it counts.
CRNA School Competition: How Hard Is It To Get Into CRNA School? – Understand what makes CRNA admissions so competitive and how to rise above other applicants.
How to Find a CRNA to Shadow + Questions to Ask When Shadowing a CRNA — Get the CRNA Shadowing experience you need for CRNA school requirements plus learn what to ask the CRNA during your shadowing experience
Why Choose CSPA Over Other Prep Programs? – Learn how guidance rooted in real CRNA admissions experience helps remove the guesswork and gives you clarity tailored to your unique & specific goals, background, and timeline.
Important Links
Join the Free CSPA Community! Connect with Aspiring CRNAs, Nurse Anesthesia Residents, practicing CRNAs, and CRNA Program Faculty Mentors who are ready to support you. Get real answers and expert guidance in a welcoming space that’s free from misinformation and negativity. You don’t have to do this alone! Join Now: https://www.cspaedu.com/community
Get access to application & interview preparation resources plus ICU Educational Workshops that have helped thousands of nurses accelerate their CRNA success. Become a member of CRNA School Prep Academy: https://community.crnaschoolprepacademy.com/join-cspa
Want Guaranteed CRNA School Admission? Learn More about the CSPA Money Back Guarantee here: https://community.crnaschoolprepacademy.com/6-12-month-intensive
Get CRNA School insights sent straight to your inbox! Sign up for the CSPA email newsletter: https://community.crnaschoolprepacademy.com/email-sign-up
Book a mock interview, resume or personal statement critique, transcript review and more: www.teachrn.com